As per Washington state guidance, masks are required regardless of vaccination status in all of our facilities. Please be aware that if you do not have a mask when you arrive we can provide one for you or reschedule your appointment. Exposure to someone that has tested positive for COVID requires a 14 day wait time regardless of vaccination status or a negative test before being seen in person. We appreciate your understanding!

Vidofludimus Calcium

Caldose -1: A phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis

  • Male or female 18 - 80 with UC
  • Mayo score: >/= 2 Stool Freq; >/= 1 Rectal Bleeding; MES >/= 2
  • Biological/Immunomodulator Failed or inadequate response/intolerance/dependent to steroids
  • Induction, Extended Induction, Maintenance, and Open label phases in trial; Up to 10 years
  • Oral Doses: 5mg vs 15mg vs 22.5mg vs placebo; 1:1:1:1. All receive drug in open label phase

If you are interested in participating in clinical studies, please send an email to

17 Locations Focused on Serving Your Needs

Email us at